Literature DB >> 12069850

On the mechanism of bile acid inhibition of rat sterol 12alpha-hydroxylase gene (CYP8B1) transcription: roles of alpha-fetoprotein transcription factor and hepatocyte nuclear factor 4alpha.

Yizeng Yang1, Ming Zhang, Gosta Eggertsen, John Y L Chiang.   

Abstract

The sterol 12alpha-hydroxylase (CYP8B1) is a key enzyme of the bile acid biosynthetic pathway. It regulates the composition of bile acids in bile, i.e. ratio between cholic acid (CA) and chenodeoxycholic acid (CDCA). In similarity with cholesterol 7alpha-hydroxylase (CYP7A1), this enzyme is subjected to a negative feedback regulation by bile acids. It has been recently reported that bile acid-activated farnesoid X receptor (FXR) induces the small heterodimer partner (SHP) that interacts with alpha-fetoprotein transcription factor (FTF) and down-regulates CYP7A1 transcription. We studied whether the same mechanism also regulated rat CYP8B1 gene transcription. Feeding rats with CDCA caused a 40-50% decrease of CYP8B1 and hepatocyte nuclear factor 4alpha (HNF4alpha) mRNA expression levels. This was associated with an increase in FTF mRNA expression, but SHP mRNA expression was not altered. Electrophoretic mobility shift assay (EMSA) and transient transfection assay of promoter/reporter genes coupled to mutagenesis analysis identified a putative bile acid response element (BARE) that has an HNF4alpha binding site embedded in two overlapping FTF binding sites. Mutation of the HNF4alpha binding site markedly reduced basal promoter activity and its repression by bile acids. Cotransfection with FTF strongly repressed CYP8B1 transcription. Interestingly, HNF4alpha could overcome the inhibitory effects of FTF and bile acids. We conclude that FTF and HNF4alpha not only play critical roles on CYP8B1 gene transcription, but also mediate bile acid feedback inhibition. This study reveals a novel mechanism by which bile acids inhibit rat CYP8B1 gene transcription by inducing FTF and inhibiting HNF4alpha expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069850     DOI: 10.1016/s1388-1981(02)00186-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development.

Authors:  Peili Gu; Bryan Goodwin; Arthur C-K Chung; Xueping Xu; David A Wheeler; Roger R Price; Cristin Galardi; Li Peng; Anne M Latour; Beverly H Koller; Jan Gossen; Steven A Kliewer; Austin J Cooney
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 2.  Role of nuclear receptor SHP in metabolism and cancer.

Authors:  Yuxia Zhang; Curt H Hagedorn; Li Wang
Journal:  Biochim Biophys Acta       Date:  2010-10-20

Review 3.  Physiological and molecular biochemical mechanisms of bile formation.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 4.  Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment.

Authors:  Karolina E Zaborska; Bethany P Cummings
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

Review 5.  Interaction of gut microbiota with bile acid metabolism and its influence on disease states.

Authors:  Alexander Khoruts; Michael J Sadowsky; Christopher Staley; Alexa R Weingarden
Journal:  Appl Microbiol Biotechnol       Date:  2016-11-25       Impact factor: 4.813

Review 6.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 7.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

Review 8.  Bile acids: regulation of synthesis.

Authors:  John Y L Chiang
Journal:  J Lipid Res       Date:  2009-04-03       Impact factor: 5.922

9.  FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway.

Authors:  Dongju Jung; J Philippe York; Li Wang; Chaofeng Yang; Aijun Zhang; Heather L Francis; Paul Webb; Wallace L McKeehan; Gianfranco Alpini; Gene D Lesage; David D Moore; Xuefeng Xia
Journal:  Pflugers Arch       Date:  2013-09-26       Impact factor: 3.657

Review 10.  Endocrine and paracrine role of bile acids.

Authors:  Verena Keitel; Ralf Kubitz; Dieter Häussinger
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.